TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16033749

Group type: EXPERIMENTAL
Intervention: Topical tetracycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose azithromycin for the surgical patient
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-dose azithromycin for the surgical patient and all household members
Number of subjects: 0
Study: 11894033

Group type: EXPERIMENTAL
Intervention: Early carotid endarterectomy (CEA) performed within 30 days after stroke
Number of subjects: 86

Group type: COMPARATOR
Intervention: Delayed carotid endarterectomy (CEA) performed more than 30 days after stroke
Number of subjects: 86
Study: 9568825

Group type: EXPERIMENTAL
Intervention: 1alpha-hydroxyvitamin D2 (1alphaD2), 10 microg thrice weekly with haemodialysis
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 1alpha-hydroxyvitamin D2 (1alphaD2)
Number of subjects: 80
Study: 7766795

Group type: COMPARATOR
Intervention: Likelihood ratio test for cancer screening trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Likelihood ratio test
Number of subjects: 0
Study: 2495220

Group type: EXPERIMENTAL
Intervention: Defined enteral nutrition (nasogastric tube feeding)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Spontaneous oral intake (control group)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Defined enteral nutrition
Number of subjects: 26
Study: 337144

Group type: EXPERIMENTAL
Intervention: Weight-reduction program (Group I and Group IIa)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No dietary program (Group IIb)
Number of subjects: 83
Study: 30860409

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (no Kinesio Taping)
Number of subjects: 22
Study: 31867652

Group type: EXPERIMENTAL
Intervention: Framing nicotine reduction as cigarettes no longer relieved cravings
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Framing nicotine reduction as cigarettes changed so that you would be able to quit more easily
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Framing nicotine reduction as nicotine levels were reduced by 95%
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Framing nicotine reduction as the government reduced nicotine levels by 95%
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Framing nicotine reduction as cigarettes were no longer addictive
Number of subjects: 1198
Study: 28007331

Group type: EXPERIMENTAL
Intervention: Combination therapy (rosuvastatin 5 mg/ezetimibe 10 mg, rosuvastatin 10 mg/ezetimibe 10 mg, rosuvastatin 20 mg/ezetimibe 10 mg)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Monotherapy (rosuvastatin 5 mg, rosuvastatin 10 mg, rosuvastatin 20 mg)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 245

Group type: COMPARATOR
Intervention: Monotherapy
Number of subjects: 245
Study: 25997043

Group type: EXPERIMENTAL
Intervention: Purified anthocyanin (320 mg/d)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 23537967

Group type: EXPERIMENTAL
Intervention: Prehospital administration of ticagrelor 180 mg followed by matching placebo in hospital
Number of subjects: 1770

Group type: COMPARATOR
Intervention: Prehospital administration of placebo followed by ticagrelor 180 mg in hospital
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily for 30 days (for all patients)
Number of subjects: 1770
Study: 20561768

Group type: EXPERIMENTAL
Intervention: Cognitive remediation (IPT-cog)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual rehabilitative interventions
Number of subjects: 32
Study: 19802534

Group type: EXPERIMENTAL
Intervention: Shenshao Tablet (SST)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 16426085

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (50 units/axilla)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Number of subjects: 40
Study: 15297779

Group type: EXPERIMENTAL
Intervention: Pantoprazole 20 mg once daily in the morning
Number of subjects: 338

Group type: COMPARATOR
Intervention: Ranitidine 300 mg once daily in the evening
Number of subjects: 338
Study: 11531680

Group type: EXPERIMENTAL
Intervention: Intravenous remifentanil 0.3 microg.kg(‐1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Sodium chloride 0.9% (control)
Number of subjects: 86
Study: 9258989

Group type: EXPERIMENTAL
Intervention: Cotinine fumarate (40, 80, or 160 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cotinine
Number of subjects: 0
Study: 7506841

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 327

Group type: COMPARATOR
Intervention: Dextran-70
Number of subjects: 327
Study: 3474889

Group type: EXPERIMENTAL
Intervention: Orthodontic force applied via coil spring between maxillary premolars
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (premolars extracted without orthodontic force)
Number of subjects: 0
Study: 28703421

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) with supportive treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Supportive treatment only
Number of subjects: 18
Study: 27143144

Group type: EXPERIMENTAL
Intervention: Environmental NEAT intervention plus mobile text message coaching (early texting group, n = 27)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Environmental NEAT intervention plus mobile text message coaching (delayed texting group, n = 13)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 24675203

Group type: EXPERIMENTAL
Intervention: Intravenous vancomycin
Number of subjects: 46

Group type: COMPARATOR
Intervention: Intravenous cefazolin
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both interventions (cefazolin and vancomycin)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Patients with more severe infections
Number of subjects: 46
Study: 22699036

Group type: COMPARATOR
Intervention: 15 mg nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 30 mg nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20 mg lidocaine + 30 mg nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: 40 mg lidocaine + 30 mg nitroglycerin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lidocaine + placebo
Number of subjects: 0
Study: 19320851

Group type: EXPERIMENTAL
Intervention: Ciclesonide (CIC) 320 μg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 375 μg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 18339441

Group type: EXPERIMENTAL
Intervention: Achievers (maintained glucose levels below 8mmol/L)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Non‐Achievers (did not maintain glucose levels below 8mmol/L)
Number of subjects: 234
Study: 16230722

Group type: EXPERIMENTAL
Intervention: Exenatide, 10 microg twice daily
Number of subjects: 551

Group type: COMPARATOR
Intervention: Insulin glargine, 1 daily dose titrated to maintain fasting blood glucose levels of less than 5.6 mmol/L (<100 mg/dL)
Number of subjects: 551
Study: 12235557

Group type: EXPERIMENTAL
Intervention: 4 mg dexchlorpheniramine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 9917780

Group type: EXPERIMENTAL
Intervention: Polyacrylic intraocular lens
Number of subjects: 81

Group type: COMPARATOR
Intervention: Silicone intraocular lens
Number of subjects: 81

Group type: COMPARATOR
Intervention: PMMA intraocular lens
Number of subjects: 81
Study: 8562293

Group type: EXPERIMENTAL
Intervention: Litoxetine (twice daily for 4 days)
Number of subjects: 0
Study: 2405742

Group type: EXPERIMENTAL
Intervention: Removal of platelet‐poor plasma (PPP)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Removal of platelet‐rich plasma (PRP)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No plasmapheresis (control group)
Number of subjects: 45
Study: 6988006

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroid treatment (betamethasone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/untreated group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bèta‐adrenergic drugs (orciprenaline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prolonged ruptured membranes
Number of subjects: 0
Study: 31823552

Group type: EXPERIMENTAL
Intervention: Autologous PRP intra-articular injection (Group A)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (Group B)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy combined with autologous PRP injection (Group C)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 180
Study: 29089344

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus
Number of subjects: 8966

Group type: COMPARATOR
Intervention: No Diabetes Mellitus
Number of subjects: 8966
Study: 25273923

Group type: EXPERIMENTAL
Intervention: Walking without optic flow (Ganzfeld goggles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal vision (control group)
Number of subjects: 0
Study: 24315046

Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PVP)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conservative treatment (CT)
Number of subjects: 96
Study: 22978595

Group type: EXPERIMENTAL
Intervention: Turmeric rhizome powder (TRP) 25 g/kg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Turmeric rhizome powder (TRP) 50 g/kg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Turmeric rhizome powder (TRP) 75 g/kg
Number of subjects: 320

Group type: COMPARATOR
Intervention: Turmeric rhizome powder (TRP) 0 g/kg (Control)
Number of subjects: 320
Study: 20003205

Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (Hyalubrix) injections
Number of subjects: 42

Group type: COMPARATOR
Intervention: Local anesthetic (mepivacaine)
Number of subjects: 42
Study: 17154678

Group type: EXPERIMENTAL
Intervention: Pholcodine
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 129
Study: 12875478

Group type: EXPERIMENTAL
Intervention: Lacidipine 4 mg o.d.
Number of subjects: 1882

Group type: COMPARATOR
Intervention: Chlorthalidone 12.5 mg o.d.
Number of subjects: 1882

Group type: EXPERIMENTAL
Intervention: Both treatments (Lacidipine and Chlorthalidone)
Number of subjects: 1882
Study: 10383520

Group type: EXPERIMENTAL
Intervention: LTdbCA (lansoprazole 30 mg b.d., tri-potassium dicitrato bismuthate one tablet b.d., clarithromycin 250 mg b.d., amoxycillin 1 g b.d. for 3 days)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: RbcCA (ranitidine bismuth citrate 400 mg b.d., clarithromycin 250 mg b.d., amoxycillin 1 g b.d. for 3 days)
Number of subjects: 180

Group type: COMPARATOR
Intervention: OCM (omeprazole 20 mg b.d., clarithromycin 250 mg b.d., metronidazole 400 mg b.d. for 1 week)
Number of subjects: 180
Study: 9546929

Group type: EXPERIMENTAL
Intervention: Ticlopidine
Number of subjects: 687

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 687
Study: 1829489

Group type: EXPERIMENTAL
Intervention: Collagen-impregnated prosthesis
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Nonimpregnated prosthesis
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Aortoiliac reconstruction
Number of subjects: 41

Group type: COMPARATOR
Intervention: Cholecystectomies (control)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with vascular disease
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 41
Study: 6342133

Group type: EXPERIMENTAL
Intervention: Debrisoquin (20 mg/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Methyldopa (100 mg/day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Propranolol (160 mg/day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 31754170

Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan (Bafa Wubu of Tai Chi)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: General aerobic exercise (brisk walking)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 30497202

Group type: EXPERIMENTAL
Intervention: Subcutaneous recombinant granulocyte colony-stimulating factor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classic surgical and rehabilitative treatments
Number of subjects: 0
Study: 27267503

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy-weight gain (IPT-WG)
Number of subjects: 6
Study: 25424573

Group type: EXPERIMENTAL
Intervention: Sleep restriction (5.1 hours/night for 8 days/8 nights)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Usual sleep (6.9 hours/night for 8 days/8 nights)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Between-groups comparison
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Non-flow mediated vasodilatation (NFMD)
Number of subjects: 16
Study: 22064208

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) at doses of 0.44, 1.3, or 2.7 g/d
Number of subjects: 131
Study: 19558344

Group type: EXPERIMENTAL
Intervention: Probiotic dietary supplement
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 17955441

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 590

Group type: COMPARATOR
Intervention: Meningococcal conjugate vaccine (MCV)
Number of subjects: 590
Study: 16361050

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 140
Study: 12084664

Group type: EXPERIMENTAL
Intervention: Inhalation of 35% CO(2)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Room air inhalation
Number of subjects: 14
Study: 9708611

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (1 g administered orally before and after hemodialysis treatments)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo (administered orally before and after hemodialysis treatments)
Number of subjects: 101
Study: 7609274

Group type: EXPERIMENTAL
Intervention: Iron (200 to 250 micrograms/kg/d)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No-Iron (total parenteral nutrition without iron)
Number of subjects: 26
Study: 2227819

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (13 to 15 mg/kg/day) for 5 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 660211

Group type: EXPERIMENTAL
Intervention: Once or twice a day dosage regimens of phenytoin
Number of subjects: 0

Group type: COMPARATOR
Intervention: More frequent regimens of phenytoin
Number of subjects: 0
Study: 30942029

Group type: EXPERIMENTAL
Intervention: Auricular gold-needle therapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Auricular point pressure therapy
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Chinese herb group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Health control group
Number of subjects: 120
Study: 29125542

Group type: EXPERIMENTAL
Intervention: Slowly digestible starch (SDS) in an instant pudding
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Slowly digestible starch (SDS) in a cold-pressed bar
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 14
Study: 26133284

Group type: EXPERIMENTAL
Intervention: PVI with LAA closure
Number of subjects: 89

Group type: COMPARATOR
Intervention: PVI-only
Number of subjects: 89
Study: 23933422

Group type: EXPERIMENTAL
Intervention: Individualized home-based caregiver-training program
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (written instructions and social telephone follow-ups)
Number of subjects: 129
Study: 21689269

Group type: EXPERIMENTAL
Intervention: CD-ROM-based program for breastfeeding mothers
Number of subjects: 476

Group type: COMPARATOR
Intervention: Control (usual post-natal care)
Number of subjects: 476
Study: 19193267

Group type: EXPERIMENTAL
Intervention: Surgical masks
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Non‐fit‐tested P2 masks
Number of subjects: 286

Group type: COMPARATOR
Intervention: No masks
Number of subjects: 286
Study: 16806625

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional agents
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Clozapine or Olanzapine
Number of subjects: 49
Study: 14602781

Group type: EXPERIMENTAL
Intervention: 300 microg E2 alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 300 microg E2 combined with oral dydrogesterone (20 mg/d) during the last 14 days
Number of subjects: 24
Study: 11252656

Group type: EXPERIMENTAL
Intervention: Lithium prophylaxis
Number of subjects: 0
Study: 8775337

Group type: EXPERIMENTAL
Intervention: Quinidine fumarate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 120

Group type: COMPARATOR
Intervention: No antiarrhythmic drugs (Control)
Number of subjects: 120
Study: 1599061

Group type: EXPERIMENTAL
Intervention: Thoracic epidural 0.2% bupivacaine combined with fentanyl
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thoracic epidural 0.2% bupivacaine alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: Thoracic epidural fentanyl alone
Number of subjects: 30

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 30
Study: 6562990

Group type: EXPERIMENTAL
Intervention: Intravaginal application of oestriol tablets (1 to 3 mg daily for 1 or more cycles)
Number of subjects: 81
Study: 31421665

Group type: EXPERIMENTAL
Intervention: Hatha yoga training (60 minutes per session, 3 times per week for 8 weeks)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Hatha yoga training
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (normal activities)
Number of subjects: 27
Study: 31500690

Group type: EXPERIMENTAL
Intervention: Loading dose of 60,000 IU weekly for 2 weeks (insufficient levels) or 6 weeks (deficient levels)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Maintenance supplements of 1,000 IU/day for those with normal serum 25(OH)D levels
Number of subjects: 71
Study: 30290685

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 400 IU/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU/day
Number of subjects: 0
Study: 26857706

Group type: EXPERIMENTAL
Intervention: Usual medical care plus chiropractic care
Number of subjects: 750

Group type: COMPARATOR
Intervention: Usual medical care alone
Number of subjects: 750
Study: 24467625

Group type: EXPERIMENTAL
Intervention: Migraine patients
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Migraine patients (males)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy age-matched participants (control)
Number of subjects: 29
Study: 22776106

Group type: EXPERIMENTAL
Intervention: IVIG treatment (Xepol® 50 mg/ml)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (OND subjects)
Number of subjects: 41
Study: 20553388

Group type: EXPERIMENTAL
Intervention: Normal D-dimer, males younger than 65
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Normal D-dimer, patients aged 65 or older
Number of subjects: 1265

Group type: EXPERIMENTAL
Intervention: Normal D-dimer, overall recurrence rates
Number of subjects: 1265
Study: 17405803

Group type: EXPERIMENTAL
Intervention: Balance exercise group (n=17)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Falls prevention education group (n=19)
Number of subjects: 36
Study: 15878564

Group type: EXPERIMENTAL
Intervention: Immediate ATP
Number of subjects: 22

Group type: COMPARATOR
Intervention: Delayed ATP
Number of subjects: 22
Study: 11912358

Group type: EXPERIMENTAL
Intervention: Both-flaps group (trabeculectomy with intraoperative mitomycin C application under conjunctival and scleral flaps)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Subconjunctival group (subconjunctival application of mitomycin C)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both-flaps group
Number of subjects: 44

Group type: COMPARATOR
Intervention: Subconjunctival group
Number of subjects: 44
Study: 11547514

Group type: EXPERIMENTAL
Intervention: 2 mg reboxetine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 4 mg reboxetine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Reboxetine (2 mg and 4 mg)
Number of subjects: 24
Study: 9041914

Group type: EXPERIMENTAL
Intervention: Methylprednisolone sodium succinate 90 minutes before induction of anesthesia and epidural analgesia (group 1, n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo 90 minutes before anesthesia and epidural analgesia (group 2, n = 12)
Number of subjects: 24
Study: 8195265

Group type: EXPERIMENTAL
Intervention: Enteral support during operative procedures
Number of subjects: 80

Group type: COMPARATOR
Intervention: Withheld enteral support during operative procedures
Number of subjects: 80
Study: 3140587

Group type: EXPERIMENTAL
Intervention: Bromocriptine 5 mg daily for 4 cycles
Number of subjects: 22

Group type: COMPARATOR
Intervention: Matching placebo for 4 cycles
Number of subjects: 22
Study: 29426008

Group type: EXPERIMENTAL
Intervention: Colchicine (0.5 mg twice-daily)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 26830645

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 89

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 89
Study: 25812927

Group type: EXPERIMENTAL
Intervention: In-person brief intervention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Computerized brief intervention
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Baseline drug problem severity
Number of subjects: 360
Study: 23796558

Group type: EXPERIMENTAL
Intervention: Routine anticoagulation (n = 450)
Number of subjects: 673

Group type: COMPARATOR
Intervention: Risk stratification and selective anticoagulation (n = 450)
Number of subjects: 673
Study: 21062779

Group type: EXPERIMENTAL
Intervention: Staccato reperfusion (SR)
Number of subjects: 39
Study: 18264130

Group type: EXPERIMENTAL
Intervention: Dipyridamole (7.4 nmol min(‐1) per 100 ml forearm)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Caffeine (90 microg min(‐1) per 100 ml volume)
Number of subjects: 40
Study: 16800099

Group type: EXPERIMENTAL
Intervention: Topical nimesulide gel (Sulidin gel 1%)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Oral nimesulide (Mesulid tablet, 2 x 100 mg)
Number of subjects: 97